Europe Oligonucleotide Synthesis market is expected to reach US$ 315.0 Bn by 2027 with CAGR of 6.9%.
Oligonucleotides have many applications in research, diseases diagnosis, therapeutics, forensic, drug discovery, agriculture and many more. Synthetic oligonucleotides are widely used in the diagnosis of human genetic diseases. In addition, the players operating in the UK have been obtaining funds in order to enhance their product offering. The growth of the market is driven by the factors such as, research and academic universities are collaborating with commercial market players to develop techniques and simplify the method of artificial DNA synthesis as well as rise in the number of market players and their focus in the oligonucleotide synthesis are likely to boost the growth of the oligonucleotide synthesis in the region during the forecast period.
Synthetic DNA is widely used in biology. Oligonucleotides are used in many biological and forensic applications as sequence-specific binding agents can help in identifying presence of a specific target DNA sequence. Synthetic oligonucleotides are short stretches of single stranded DNA fragments assembled by chemical synthesis. Due to the simultaneous developments of methods for the rapid and efficient synthesis of oligonucleotides and the advent of molecular biology techniques.
The Business Market Insights subscription helps clients understand the ongoing market trends, identify opportunities, and make informed decisions through the reports in the Subscription Platform. The Industry reports available in the subscription provide an in-depth analysis on various market topics and enable clients to line up remunerative opportunities. The reports provide the market size & forecast, drivers, challenges, trends, and more.
Get free trial subscription and gain instant access to our market research reports at
Spain is expected to lead the market in the Europe region owing to growing number of partnerships and collaborations among private players, rising investments and funding dedicated to the biotechnology companies as well as academic and research institutes for gene synthesis based end products. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Europe region during the forecast period.
Business Market Insights reports focus upon client objectives, use standard research methodologies and exclusive analytical models, combined with robust business acumen, which provides precise and insightful results.
Business Market Insights reports are useful not only for corporate and academic professionals but also for consulting, research firms, PEVC firms, and professional services firms.
EUROPE OLIGONUCLEOTIDE SYNTHESIS – MARKET SEGMENTATION
By End User
Academic Research Institutes
Pharmaceutical & Biotechnology Companies
Other End Users
Thermo Fisher Scientific Inc.
Full Report subscription with pay as per requirement at
(30-day subscription plans prove to be very cost-effective with no compromise on the quality of reports)
Benefits with Business Market Insights
About Business Market Insights
Based in New York, Business Market Insights is a one-stop destination for in-depth market research reports from various industries including Technology, Media & Telecommunications, Semiconductor & Electronics, Aerospace & Defense, Automotive & Transportation, Biotechnology, Technology, Media and Telecommunications IT, Manufacturing & Construction, Medical Device, and Chemicals & Materials. The clients include corporate and academic professionals, consulting, research firms, PEVC firms, and professional services firms.
For Subscription contact
Business Market Insights